Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Molecular Devices Launches Axon Digidata 1550 Low-Noise Data Acquisition System

Published: Thursday, May 09, 2013
Last Updated: Thursday, May 09, 2013
Bookmark and Share
High performance, high throughput system designed to support the most challenging electrophysiology research.

Molecular Devices® has announced the launch of its next generation Axon™ Digidata® 1550 Low-Noise Data Acquisition System. Considered the industry standard in neuroscience research labs, the new Digidata Platform enables the parallel patching of up to eight cells simultaneously to provide better insight of neuronal network function and capture more data points per experiment.  This new system extends the precision and quality of the existing Axon Digitizer platform to include a higher sampling rate to monitor rapid responders, combined with enhanced performance in low-noise, high resolution 16-bit data acquisition.DD-1550-Angle-lo.gif

The Digidata 1550 Digitizer features eight independent analog output channels to simultaneously send command waveforms to multiple cells at one time, essential for higher throughput toxicology experiments or to study synaptic function in complex neuronal networks. Combined with a sampling rate of up to 500 kHz per channel, the Digidata 1550 Digitizer allows researchers to gather more data points in demanding experiments such as nanopore and bilayer studies. This rapid rate monitors the fastest of signals in the biorelevant frequency range, whilst achieving a total data throughput rate of 4 mega-samples per second. Independent analog-to-digital converters for each input channel also ensure low crosstalk levels and high data acquisition rates, making the system one of the quietest digitizers on the market.

Designed for intuitive set-up and fast results, the Digidata 1550 Digitizer comes with AxoScope Data Acquisition Software for Microsoft Windows OS (Windows 7 32- or 64-bit) and is ready to acquire data immediately after installation - absolutely no programming is necessary.

Klaus Lun, Vice President of Product Marketing at Molecular Devices commented: "The Digidata 1550 Digitizer builds on Molecular Devices' experience in electrophysiology and biophysical research fields. Our commitment to bring additional utility to the conventional electrophysiology hardware and software allows our customers further understanding of neuronal networks, allowing researchers to make better, quicker decisions based on robust data.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Devices to attend ADME & Predictive Toxicology Europe
Company is to showcase its SpectraMax® Paradigm® microplate reader during the European conference in Munich, Germany, 13-14 March 2012.
Wednesday, February 29, 2012
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!